🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/04/2004 | 11,51 | 11,79 | 11,42 | 11,68 | +1,74% | 3,17% | 1.017.600 |
| 21/04/2004 | 11,29 | 11,55 | 11,19 | 11,48 | +1,59% | 3,23% | 390.400 |
| 20/04/2004 | 11,47 | 11,60 | 11,23 | 11,30 | -1,82% | 3,18% | 375.400 |
| 19/04/2004 | 11,37 | 11,52 | 11,32 | 11,51 | +1,14% | 1,80% | 424.600 |
| 16/04/2004 | 11,38 | 11,59 | 11,27 | 11,38 | +0,00% | 2,81% | 290.400 |
| 15/04/2004 | 11,32 | 11,53 | 11,19 | 11,38 | +0,22% | 3,05% | 569.000 |
| 14/04/2004 | 11,48 | 11,70 | 11,29 | 11,36 | -1,48% | 3,53% | 375.400 |
| 13/04/2004 | 11,98 | 12,05 | 11,47 | 11,53 | -3,56% | 4,88% | 583.400 |
| 12/04/2004 | 11,86 | 11,95 | 11,85 | 11,95 | +0,63% | 0,84% | 654.200 |
| 08/04/2004 | 12,05 | 12,11 | 11,85 | 11,88 | -0,84% | 2,12% | 357.200 |
| 07/04/2004 | 12,25 | 12,28 | 11,98 | 11,98 | -2,24% | 2,45% | 850.200 |
| 06/04/2004 | 12,31 | 12,32 | 12,13 | 12,25 | -0,49% | 1,50% | 388.800 |
| 05/04/2004 | 11,97 | 12,41 | 11,96 | 12,31 | +1,99% | 3,76% | 488.400 |
| 02/04/2004 | 11,92 | 12,35 | 11,92 | 12,07 | +1,77% | 3,65% | 644.000 |
| 01/04/2004 | 11,95 | 11,95 | 11,65 | 11,86 | -0,46% | 2,51% | 595.800 |
| 31/03/2004 | 12,14 | 12,34 | 11,62 | 11,92 | -1,53% | 5,89% | 2.085.400 |
| 30/03/2004 | 12,03 | 12,15 | 11,95 | 12,10 | +0,67% | 1,70% | 173.400 |
| 29/03/2004 | 11,81 | 12,05 | 11,76 | 12,02 | +2,56% | 2,46% | 983.400 |
| 26/03/2004 | 11,80 | 11,83 | 11,67 | 11,72 | -0,68% | 1,36% | 768.200 |
| 25/03/2004 | 11,60 | 11,94 | 11,58 | 11,80 | +1,72% | 3,15% | 328.800 |
| 24/03/2004 | 11,55 | 11,75 | 11,41 | 11,60 | +0,61% | 2,94% | 335.000 |
| 23/03/2004 | 11,70 | 11,75 | 11,43 | 11,53 | -0,60% | 2,74% | 571.200 |
| 22/03/2004 | 12,00 | 12,02 | 11,47 | 11,60 | -4,33% | 4,58% | 649.200 |
| 19/03/2004 | 12,00 | 12,13 | 11,88 | 12,13 | +1,68% | 2,04% | 856.400 |
| 18/03/2004 | 11,78 | 12,01 | 11,75 | 11,93 | +0,85% | 2,17% | 675.400 |
| 17/03/2004 | 11,84 | 11,93 | 11,77 | 11,83 | +0,60% | 1,35% | 521.600 |
| 16/03/2004 | 11,70 | 11,81 | 11,61 | 11,76 | +1,12% | 1,75% | 519.600 |
| 15/03/2004 | 12,13 | 12,13 | 11,61 | 11,63 | -3,81% | 4,25% | 264.200 |
| 12/03/2004 | 11,70 | 12,12 | 11,65 | 12,09 | +3,11% | 4,06% | 465.600 |
| 11/03/2004 | 11,63 | 12,12 | 11,62 | 11,72 | +0,82% | 4,30% | 830.600 |